Zardo, William ORCID: 0000-0002-2078-2746, Villa, Emanuele, Corti, Eleonora, Moriggi, Tommaso, Radaelli, Giorgia, Ferri, Alessandra ORCID: 0000-0003-0457-6931, Marzorati, Mauro ORCID: 0000-0003-1093-2162, Eirale, Cristiano, Vago, Paola ORCID: 0000-0002-0451-8144, Biondi, Andrea ORCID: 0000-0002-6757-6173, Jankovic, Momcilo ORCID: 0000-0001-9773-0576, Balduzzi, Adriana ORCID: 0000-0002-5879-0610 and Lanfranconi, Francesca ORCID: 0000-0001-5777-0821 (2022) The impact of a precision-based exercise intervention in childhood hematological malignancies evaluated by an adapted yo-yo intermittent recovery test. Cancers, 14 (5). ISSN 2072-6694

Abstract

During cancer treatments in childhood hematological malignancies, reduced exercise tolerance is one of the main hardships. Precision-based training programs help children, adolescents, and young adults and their families to resume regular physical activity, exercise, and sports once they return to their communities after the intensive phases spent in hospital. This study was aimed at verifying whether an intermittent recovery test, the Yo-Yo AD, could provide a simple and valid way to evaluate an individual’s capacity to perform repeated intense exercise and to follow up on the impact of tailored exercise in children, adolescents, and young adults with hematological malignancies. The Yo-Yo AD involved the repetition of several shuttles to muscle exhaustion, at pre-established speeds (walking and slow running). The heart rate (HR) and oxygen saturation (SaO2 ) were monitored during the test. The total distance and the walking/running ability, measured as the slope of the HR vs. distance correlation, were investigated before (T0) and after 11 weeks (T1) of precision exercise intervention. The Yo-Yo AD was also performed by healthy children (CTRL). Ninety-seven patients (10.58 ± 4.5 years, 46% female) were enrolled. The Yo-Yo AD showed the positive impact of the exercise intervention by increasing the distance covered by the individuals (T0 = 946.6 ± 438.2 vs. T1 = 1352.3 ± 600.6 m, p < 0.001) with a more efficient walking/running ability (T0 = 2.17 ± 0.84 vs. T1 = 1.73 ± 0.89 slope, p < 0.0164). CTRLs performed better (1754.0 ± 444.0 m, p = 0.010). They were equally skillful (1.71 ± 0.27 slope) when compared to the patients after they received the precision-based intervention. No adverse events occurred during the Yo-Yo AD and it proved to be an accurate way of correctly depicting the changes in performance in childhood hematological malignancies.

Search Google Scholar

Repository staff login